Physician profile
Patrick R Frey
NPI 1932195328
$4,375.91
in general payments reported to CMS, 2019-2025
46 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $184 · 2021: $305 · 2022: $469 · 2023: $559 · 2024: $587 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,665 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,664.55 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $603.90 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Lithovue |
| Pfizer INC. | $473.13 | 2019-2025 | |
| Antares Pharma, INC. | $335.27 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Dendreon Pharmaceuticals LLC | $259.19 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $236.27 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $229.68 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $217.25 | 2019-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $183.98 | 2024-2025 | Adstiladrin |
| Merck Sharp & Dohme LLC | $147.93 | 2021-2025 | Lynparza, Keytruda |
| Procept Biorobotics Corporation | $143.12 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Urogen Pharma, INC. | $138.00 | 2021-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $126.37 | 2025 | |
| Abbvie INC. | $123.47 | 2019-2025 | |
| Innovation Technologies INC | $94.64 | 2022-2024 | Irrisept |
| Olympus America INC. | $82.34 | 2019-2025 | Itind System |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.